2003;41:1329 40. 308. Chaowalit N, McCully RB, Callahan MJ, et al. Outcomes after normal dobutamine stress echocardiography and predictors of adverse events: long-term follow-up of 3014 patients. Eur Heart J. 2006;27:3039 44. 309. Elhendy A, Mahoney DW, Khandheria BK, et al. Prognostic signif- icance of the location of wall motion abnormalities during exercise echocardiography. J Am Coll Cardiol. 2002;40:1623 9. 310. Hachamovitch R, Berman DS, Shaw LJ, et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: differential stratifi- cation for risk of cardiac death and myocardial infarction. Circulation. 1998;97:535 43. 311. Marwick TH, Case C, Vasey C, et al. Prediction of mortality by exercise echocardiography: a strategy for combination with the Duke treadmill score. Circulation. 2001;103:2566 71. 312. Marwick TH, Case C, Sawada S, et al. Prediction of mortality using dobutamine echocardiography. J Am Coll Cardiol. 2001;37:754 60. 313. Shaw LJ, Hachamovitch R, Heller GV, et al. Noninvasive strategies for the estimation of cardiac risk in stable chest pain patients. The Eco- nomics of Noninvasive Diagnosis (END) Study Group. Am J Cardiol. 2000;86:1 7. 314. Shaw LJ, Hendel RC, Cerquiera M, et al. Ethnic differences in the prognostic value of stress technetium-99m tetrofosmin gated single- photon emission computed tomography myocardial perfusion imaging. J Am Coll Cardiol. 2005;45:1494 504. 315. Shaw LJ, Vasey C, Sawada S, et al. Impact of gender on risk stratifi- cation by exercise and dobutamine stress echocardiography: long-term mortality in 4234 women and 6898 men. Eur Heart J. 2005;26:447 56. 316. Gibbons RJ, Hodge DO, Berman DS, et al. Long-term outcome of patients with intermediate-risk exercise electrocardiograms who do not have myocardial perfusion defects on radionuclide imaging. Circu- lation. 1999;100:2140 5. 317. Hachamovitch R, Berman DS, Kiat H, et al. 